The treatment is to create a domestic manufacturing capability, undertake new production technologies, and alter what’s saved in the Strategic National Stockpile. This would require a partnership between the public and private sectors.The array of new modalities is poised for speedy growth. Antibody-linked products make up one wave of expansion.